Annual Drug Patent Expirations for XOPENEX+HFA
Xopenex Hfa is a drug marketed by Lupin and is included in one NDA. It is available from five suppliers. There are two patents protecting this drug.
XOPENEX HFA drug price trends.
Drug patent litigation for XOPENEX HFA.
This drug has twenty-eight patent family members in eighteen countries.
The generic ingredient in XOPENEX HFA is levalbuterol tartrate. Five suppliers are listed for this compound. Additional details are available on the levalbuterol tartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com